Search Results - "Niphadkar, Seema"
-
1
Amivantamab plus lazertinib vs osimertinib in first-line EGFR -mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA study
Published in Journal of clinical oncology (01-06-2024)“…8504 Background: Amivantamab (ami) is an EGFR-MET bispecific antibody with immune cell-directing activity. Lazertinib (laz) is a CNS-penetrant, 3 rd…”
Get full text
Journal Article -
2
Acute Myeloid Leukemia in the Elderly: Trends in Mortality Rates, Hospital Cost, Length of Stay, and Complication Rates in Patients Aged 60 and Older
Published in Blood (02-12-2016)“…Background: Acute myeloid leukemia (AML) is associated with a high mortality rate. Advancing age is a risk factor associated with poor prognosis and an…”
Get full text
Journal Article -
3
Emerging trends in pancreatic cancer and diabetes
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e13077 Background: Risk factors for cancer and diabetes mellitus (DM) include aging, obesity, smoking, and physical inactivity. Present studies…”
Get full text
Journal Article -
4
Autologous Stem Cell Transplant: A Cost Effective and Efficacious Treatment for Newly Diagnosed Multiple Myeloma
Published in Blood (02-12-2016)“…Background: Induction chemotherapy followed by autologous stem cell transplantation (ASCT) is considered a standard of care for appropriate patients with newly…”
Get full text
Journal Article -
5
Pulmonary embolism prophylaxis in solid tumors: Exploring a paradigm shift
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e18252 Background: Studies have found higher risk of development of pulmonary embolism (PE) in those with metastatic disease within the first…”
Get full text
Journal Article -
6
Prevalence and mortality of colorectal cancer with iron deficiency anemia in the South
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e15141 Background: The Centers for Disease Control and Prevention has published data on incidence rates of colorectal cancer (CRC) referenced…”
Get full text
Journal Article